Scout provides molecular diagnostic testing that achieves 99% agreement with high-complexity PCR results in 30 minutes. This patented technology eliminates the trade-off between accuracy, speed, and cost often seen in traditional diagnostics. The ultra-portable system enables decisive, near-patient diagnosis and treatment in various care settings.
Funding
$3.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional home health tests often lack the accuracy of lab-based diagnostics, leading to unreliable results and potentially impacting health decisions. The inconvenience and turnaround time associated with lab testing can also delay diagnosis and treatment.
Solution
Scout provides a nucleic acid testing platform that delivers lab-grade diagnostic accuracy in a home or point-of-care setting. The system utilizes patented technology to achieve 99% accuracy compared to traditional lab tests, providing more reliable results than conventional disposable home tests. Results are available in approximately 30 minutes, enabling faster diagnosis and timely intervention. The platform consists of a portable Hub and simple test kits, streamlining the testing process and eliminating the need for complex equipment.
Target Audience
The primary target audience includes individuals seeking convenient and accurate at-home health testing, as well as schools, offices, and community health organizations requiring rapid point-of-care diagnostics.
Features
- Nucleic acid amplification technology for high sensitivity and specificity
- Portable Hub device for on-site test processing and result analysis
- Single-use test kits for various infectious diseases
- Results available in 30 minutes
- 99% accuracy compared to lab-based PCR tests in clinical studies
- Cloud connectivity for data storage and reporting